TY - JOUR
T1 - Age- and genotype-specific triggers for life-threatening arrhythmia in the genotyped long QT syndrome
AU - Sakaguchi, Tomoko
AU - Shimizu, Wataru
AU - Itoh, Hideki
AU - Noda, Takashi
AU - Miyamoto, Yoshihiro
AU - Nagaoka, Iori
AU - Oka, Yuko
AU - Ashihara, Takashi
AU - Ito, Makoto
AU - Tsuji, Keiko
AU - Ohno, Seiko
AU - Makiyama, Takeru
AU - Kamakura, Shiro
AU - Horie, Minoru
PY - 2008/8
Y1 - 2008/8
N2 - Age and Long QT Syndrome. Introduction: Patients with long QT syndrome (LQTS) become symptomatic in adolescence, but some become at age of ≥20 years. Since it remains unknown whether clinical features of symptomatic LQTS patients differ depending on the age of onset, we aimed to examine whether triggers for cardiac events are different depending on the age in genotyped and symptomatic LQTS patients. Methods and Results: We identified 145 symptomatic LQTS patients, divided them into three groups according to the age of first onset of symptoms (young <20, intermediate 20-39, and older ≥40 years), and analyzed triggers of cardiac events (ventricular tachycardia, syncope, or cardiac arrest). The triggers were divided into three categories: (1) adrenergically mediated triggers: exercise, emotional stress, loud noise, and arousal; (2) vagally mediated triggers: rest/sleep; and (3) secondary triggers: drugs, hypokalemia, and atrioventricular (AV) block. In the young group, 78% of the cardiac events were initiated by adrenergically mediated triggers and 22% were vagally mediated, but none by secondary triggers. In contrast, the adrenergically mediated triggers were significantly lower in the intermediate group. The percentage of secondary triggers was significantly larger in the older group than in the other two groups (0% in young vs 23% in intermediate vs 72% in older; P < 0.0001). Concerning the subdivision of secondary triggers on the basis of genotype, hypokalemia was only observed in LQT1, drugs mainly in LQT2, and AV block only in LQT2. Conclusion: Arrhythmic triggers in LQTS differ depending on the age of the patients, stressing the importance of age-related therapy for genotyped LQTS patients.
AB - Age and Long QT Syndrome. Introduction: Patients with long QT syndrome (LQTS) become symptomatic in adolescence, but some become at age of ≥20 years. Since it remains unknown whether clinical features of symptomatic LQTS patients differ depending on the age of onset, we aimed to examine whether triggers for cardiac events are different depending on the age in genotyped and symptomatic LQTS patients. Methods and Results: We identified 145 symptomatic LQTS patients, divided them into three groups according to the age of first onset of symptoms (young <20, intermediate 20-39, and older ≥40 years), and analyzed triggers of cardiac events (ventricular tachycardia, syncope, or cardiac arrest). The triggers were divided into three categories: (1) adrenergically mediated triggers: exercise, emotional stress, loud noise, and arousal; (2) vagally mediated triggers: rest/sleep; and (3) secondary triggers: drugs, hypokalemia, and atrioventricular (AV) block. In the young group, 78% of the cardiac events were initiated by adrenergically mediated triggers and 22% were vagally mediated, but none by secondary triggers. In contrast, the adrenergically mediated triggers were significantly lower in the intermediate group. The percentage of secondary triggers was significantly larger in the older group than in the other two groups (0% in young vs 23% in intermediate vs 72% in older; P < 0.0001). Concerning the subdivision of secondary triggers on the basis of genotype, hypokalemia was only observed in LQT1, drugs mainly in LQT2, and AV block only in LQT2. Conclusion: Arrhythmic triggers in LQTS differ depending on the age of the patients, stressing the importance of age-related therapy for genotyped LQTS patients.
KW - Age
KW - Bradycardia
KW - Drugs
KW - Genetic test
KW - Hypokalemia
KW - Long QT syndrome
KW - Triggers
UR - http://www.scopus.com/inward/record.url?scp=47749122982&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=47749122982&partnerID=8YFLogxK
U2 - 10.1111/j.1540-8167.2008.01138.x
DO - 10.1111/j.1540-8167.2008.01138.x
M3 - Article
C2 - 18373596
AN - SCOPUS:47749122982
SN - 1045-3873
VL - 19
SP - 794
EP - 799
JO - Journal of Cardiovascular Electrophysiology
JF - Journal of Cardiovascular Electrophysiology
IS - 8
ER -